Research funder · United States
BrightFocus Foundation
Non-profit organization in the USA
- Grants since 2016
- 717
- Awarded, last 5 years (where amounts are published)
- $108M
- Funded works, last 5 years
- 1 862
- Funded works, all time
- 3 290
Grants
2026–2029 · research · Alzheimer's Disease Research: Standard
Beyond Pathology: A Spatially Resolved Multi-Omic Atlas of Cognitive Resilience in Extreme Aging
Vivek Swarup · University of California, Irvine
2026–2029 · research · Alzheimer's Disease Research: Standard
Early Protein Drivers of Alzheimer’s Disease
Eleanor Drummond · The University of Sydney
2026–2029 · research · Macular Degeneration Research: Standard
Promoting Cone Survival in Dry AMD
Ryoji Amamoto · Massachusetts Eye and Ear Infirmary
2026–2028 · research · National Glaucoma Research: Standard
Vascular Signaling Networks in Schlemm's Canal Morphogenesis and Congenital Glaucoma
Revathi Balasubramanian · Columbia University
2026–2028 · research · National Glaucoma Research: Standard
Resolving Heterogeneous Neuroinflammatory Responses in the Glaucomatous Human ONH
Jeremy Sivak · University Health Network
2026–2029 · research · Alzheimer's Disease Research: Standard
Mapping cell state transitions in brain aging to predict rejuvenating therapeutic targets
Christina Theodoris · Gladstone Institutes
2026–2028 · research · National Glaucoma Research: Standard
Development of novel, repeatable measurement of the neurovascular coupling response in human subjects with glaucoma
Stuart Gardiner · Good Samaritan Foundation, Legacy Health System
2026–2029 · research · Alzheimer's Disease Research: Standard
Identification and Validation of Clusterin (CLU) Glyco-Biomarkers for Alzheimer’s Disease
Qi Zhang · Emory University
2026–2029 · research · Alzheimer's Disease Research: Standard
Circadian deregulation exacerbates oligodendrocyte dysfunction in Alzheimer's disease
Paula Desplats · The Ohio State University
2026–2029 · research · Alzheimer's Disease Research: Standard
Immune and metabolomic protective mechanisms of novel probiotics for Alzheimer’s disease
Laura Cox · Brigham and Women's Hospital
2026–2028 · research · Macular Degeneration Research: Standard
Targeting ETS Transcription Factors to Mitigate Choroidal Atrophy in Age-Related Macular Degeneration
Eric Ma · Oklahoma Medical Research Foundation
2026–2028 · research · National Glaucoma Research: Standard
Agentic Multimodal AI System for Glaucoma Management
Mark Christopher · University of California San Diego
2026–2029 · research · Macular Degeneration Research: Standard
Mapping the Molecular-Imaging Interface in Age-Related Macular Degeneration: A Multimodal Approach
Petra Larsen · German Center for Neurodegenerative Diseases
2026–2029 · research · Alzheimer's Disease Research: Standard
Targeting Neuroinflammatory Molecules for Degradation through a Modified Mannose 6 Phosphate Receptor
Gilbert Gallardo · Washington University in St. Louis
2026–2029 · research · Macular Degeneration Research: Standard
Integrative Modeling of Liver-RPE Crosstalk to Identify Systemic Drivers of Complement Activation in AMD
Sunghee Park · Purdue University West Lafayette
2026–2029 · research · Alzheimer's Disease Research: Standard
In vivo spatiotemporal evolution of tau in the dorsal raphe nucleus: interface with (non)cognitive changes in Alzheimer's disease
Heidi Jacobs · Massachusetts General Hospital
2026–2028 · research · National Glaucoma Research: Standard
HDAC8-mediated immunomodulatory signaling in reactive optic nerve head astrocytes
Evan Cameron · Cleveland Clinic Lerner College of Medicine
2026–2028 · research · National Glaucoma Research: Standard
The role of activity in retinal circuit plasticity and repair in glaucoma
Yvonne Ou · University of California, San Francisco
2026–2027 · research · BrightFocus Foundation: Standard
Uncovering Transposable Element Exonization as a Hidden Layer of AD Genetics
Yuyun Zhang · University of California, Los Angeles
2026–2028 · research · Macular Degeneration Research: Standard
Leveraging VLC-PUFA Metabolism to Impede AMD Progression
Lily Wenjing Wu · University of Oklahoma
2026–2029 · research · Alzheimer's Disease Research: Standard
Integrative AI and Biofluid Proteomics of CSF and Plasma to Uncover Molecular Heterogeneity and Predict Longitudinal Disease Trajectories in AD/ADRD
Saima Rathore · Emory University
2026–2029 · research · Alzheimer's Disease Research: Standard
Molecular Mechanisms Underlying Autoimmune Contributions to Alzheimer’s Disease
Jennifer Yokoyama · University of California, San Francisco
2026–2028 · research · Alzheimer's Disease Research: Standard
Mapping Brain-Permeable Plasma Proteins to Define Pathways of Periphery–Brain Crosstalk in Alzheimer's Disease
Haoyue Zhou · Gladstone Institutes
2026–2028 · research · Alzheimer's Disease Research: Standard
Quantifying cerebrospinal fluid flow dynamics in Alzheimer’s disease using 4D flow MRI
Tomas Vikner · University of Wisconsin–Madison
2026–2029 · research · Alzheimer's Disease Research: Standard
Ovarian Macrophages as Drivers of Neuroinflammation and Cognitive Decline in Alzheimer's Disease
Sarah Ocañas · Oklahoma Medical Research Foundation
2026–2027 · research · National Glaucoma Research: Standard
DEVELOPMENT OF NOVEL NMNAT2-TARGETING SMALL MOLECULES FOR GLAUCOMA
Pete Williams · Karolinska Institutet
2026–2028 · research · Alzheimer's Disease Research: Standard
Prime Editing–Based Massively Parallel Profiling of Alzheimer's Disease Mutations Affecting Protein Localization in iPSC-Derived Neurons and Glia
Shamchal Bakavayev · National Institute of Neurological Disorders and Stroke
2026–2029 · research · Alzheimer's Disease Research: Standard
Investigating the neuromodulatory control of cortical cholesterol metabolism and neuronal function in AD
Fikri Birey · Emory University
2026–2027 · research · BrightFocus Foundation: Standard
Fibril-Specific AI Drug Design to Identify Tau Aggregation Inhibitors in Alzheimer’s Disease
Yuanyuan Wei · University of California, Los Angeles
2026–2027 · research · BrightFocus Foundation: Standard
lifespan perfusion TRAjectories In ageing and Alzheimer's Disease (TRAILAD)
James Cole · University College London
2026–2029 · research · Alzheimer's Disease Research: Standard
Determining if altered microglia fructose metabolism drives neurodegeneration.
Justin Perry · Memorial Sloan Kettering Cancer Center
2026–2027 · research · BrightFocus Foundation: Standard
Transethnic Molecular Profiling of AD Risk Factors and Plasma Biomarkers
María Carolina Dalmasso · Studies In Neuroscience And Complex Systems Unit
2026–2028 · research · Alzheimer's Disease Research: Standard
A comprehensive molecular mediation analysis of cardiometabolic risk factors for Alzheimer's disease
Daniel Panyard · Stanford University
2026–2028 · research · National Glaucoma Research: Standard
Spatiotemporal Dynamics and Transcriptional Remodeling of Retinal Myeloid Cells Following GLP-1R Agonist Treatment in Glaucoma
Qi Cui · University of Pennsylvania
2026–2028 · research · Alzheimer's Disease Research: Standard
Astrocyte-specific p38aMAPK in amyloid beta induced metabolic and behavioral pathology in 5xFAD mice
Caleb Bailey · University Of Kentucky Research Foundation
2026–2028 · research · Macular Degeneration Research: Standard
Elucidating the Role of Müller Glia-Mediated TLR Signaling on Peripheral Immune Recruitment in Age Related Macular Degeneration
Sarah Palko · Trinity College Dublin
2026–2028 · research · National Glaucoma Research: Standard
Primary Cilia-Mediated Regulation of Endogenous Nitric Oxide Production in Schlemm’s Canal
Myoungsup Sim · Duke University
2026–2029 · research · Alzheimer's Disease Research: Standard
Investigating the Impact of Genetic Ancestry on Mitochondrial Dysfunction in Alzheimer’s Disease
Austin Reynolds · University of North Texas Health Science Center
2026–2029 · research · Macular Degeneration Research: Standard
Probing Choriocapillaris Flow Voids and Reticular Pseudodrusen through Ocular Stress Tests
Mark Draelos · University of Michigan
2026–2028 · research · Alzheimer's Disease Research: Standard
Longitudinal Myelin Proteome and ATN Biomarker Changes as Drivers of White Matter Hyperintensities in the Jackson Heart Study
Cellas Hayes · University Of Kentucky Research Foundation